GSK360A

Names

[ Name ]:
GSK360A

[Synonym ]:
gsk360a

Biological Activity

[Description]:

GSK360A is a potent and orally active HIF-PHD inhibitor with IC50 values of 10, 100, and 126 nM for PHD1, PHD2, and PHD3, respectively. GSK360A activates the HIF-1 alpha pathway and protect the failing heart after myocardial infarction (MI) [1].

[Related Catalog]:

Research Areas >> Cardiovascular Disease

Signaling Pathways >> Metabolic Enzyme/Protease >> HIF/HIF Prolyl-Hydroxylase

[In Vivo]

GSK360A (30 mg/kg i.g.) 在已建立的心室功能障碍模型中改善长期心室功能、重塑和血管分布[1]。 Animal Model: male Lewis rats with ventricular dysfunction model[1] Dosage: 30 mg/kg Administration: oral gavage Result: Increased circulating levels of erythropoietin and hemoglobin and hemoxygenase-1 expression in the heart and skeletal muscle of male rats.

[References]

[1]. Bao W, et, al. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat. J Cardiovasc Pharmacol. 2010 Aug;56(2):147-55.

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₇H₁₇FN₂O₅

[ Molecular Weight ]:
348.33

[ Exact Mass ]:
348.11200

[ PSA ]:
112.12000

[ LogP ]:
2.03550

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.